New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Using the HALP score for prognostic ability in cancers: A literature review

Using the HALP score for prognostic ability in cancers: A literature review

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new review paper titled "What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP's p
Oncology January 04,2024
Using the HALP score for prognostic ability in cancers: A literature review

Using the HALP score for prognostic ability in cancers: A literature review

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new review paper titled "What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP's p
Oncology January 04,2024
The use of DNA biomarkers for detecting early-stage HPV-positive oropharynx cancers has limitations

The use of DNA biomarkers for detecting early-stage HPV-positive oropharynx cancers has limitations

byBrigham and Women's HospitalA double stranded DNA fragment. Credit: Vcpmartin/Wikimedia/ CC BY-SA 4.0Oropharynx cancers caused by human papillomavirus (HPV) have risen dramatically over th
Oncology January 04,2024
The use of DNA biomarkers for detecting early-stage HPV-positive oropharynx cancers has limitations

The use of DNA biomarkers for detecting early-stage HPV-positive oropharynx cancers has limitations

byBrigham and Women's HospitalA double stranded DNA fragment. Credit: Vcpmartin/Wikimedia/ CC BY-SA 4.0Oropharynx cancers caused by human papillomavirus (HPV) have risen dramatically over th
Oncology January 04,2024
Making glioblastoma more vulnerable to treatment

Making glioblastoma more vulnerable to treatment

byMedical College of Georgia at Augusta UniversityDr. Waaqo Daddacha. Credit: Michael Holahan, Augusta UniversityIn the tough war against glioblastoma, scientists are taking a cue from viruses o
Neurology January 04,2024
Making glioblastoma more vulnerable to treatment

Making glioblastoma more vulnerable to treatment

byMedical College of Georgia at Augusta UniversityDr. Waaqo Daddacha. Credit: Michael Holahan, Augusta UniversityIn the tough war against glioblastoma, scientists are taking a cue from viruses o
Neurology January 04,2024
Does eating processed meats cause colorectal cancer?

Does eating processed meats cause colorectal cancer?

by Maddie Massy-Westropp,University of New South WalesCredit: Pixabay/CC0 Public DomainThey're integral to summer, as ubiquitous as a zinced-up nose or a backyard cricket game. From December
Oncology January 04,2024
Does eating processed meats cause colorectal cancer?

Does eating processed meats cause colorectal cancer?

by Maddie Massy-Westropp,University of New South WalesCredit: Pixabay/CC0 Public DomainThey're integral to summer, as ubiquitous as a zinced-up nose or a backyard cricket game. From December
Oncology January 04,2024
Experimental brain cancer drug fast tracked in clinical trials

Experimental brain cancer drug fast tracked in clinical trials

byUniversity of South AustraliaProfessor Shudong Wang. Credit: University of South AustraliaAn experimental drug being trialed for advanced solid tumors, including the most aggressive brain canc
Oncology January 04,2024
Experimental brain cancer drug fast tracked in clinical trials

Experimental brain cancer drug fast tracked in clinical trials

byUniversity of South AustraliaProfessor Shudong Wang. Credit: University of South AustraliaAn experimental drug being trialed for advanced solid tumors, including the most aggressive brain canc
Oncology January 04,2024
Experimental ovarian cancer diagnostic could lead to new precision oncology approach

Experimental ovarian cancer diagnostic could lead to new precision oncology approach

byFred Hutchinson Cancer CenterIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (
Oncology January 04,2024
Experimental ovarian cancer diagnostic could lead to new precision oncology approach

Experimental ovarian cancer diagnostic could lead to new precision oncology approach

byFred Hutchinson Cancer CenterIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (
Oncology January 04,2024
Experimental cancer vaccine shows promise in animal studies

Experimental cancer vaccine shows promise in animal studies

byNIH/National Institute of Allergy and Infectious DiseasesGraphical abstract. Credit:Cell(2022). DOI: 10.1016/j.cell.2022.10.006An experimental therapeutic cancer vaccine induced tw
Oncology January 04,2024
Experimental cancer vaccine shows promise in animal studies

Experimental cancer vaccine shows promise in animal studies

byNIH/National Institute of Allergy and Infectious DiseasesGraphical abstract. Credit:Cell(2022). DOI: 10.1016/j.cell.2022.10.006An experimental therapeutic cancer vaccine induced tw
Oncology January 04,2024
Solid organ transplant patients may be at higher risk for skin cancer and require coordinated care

Solid organ transplant patients may be at higher risk for skin cancer and require coordinated care

by Jay Furst,Mayo ClinicCredit: AI-generated imageMore than half of all patients who receive solid organ transplants will have an incidence of skin cancer at some point—most often a nonmelanoma
Oncology January 04,2024
Solid organ transplant patients may be at higher risk for skin cancer and require coordinated care

Solid organ transplant patients may be at higher risk for skin cancer and require coordinated care

by Jay Furst,Mayo ClinicCredit: AI-generated imageMore than half of all patients who receive solid organ transplants will have an incidence of skin cancer at some point—most often a nonmelanoma
Oncology January 04,2024
Tracking radiation treatment in real time promises safer, more effective cancer therapy

Tracking radiation treatment in real time promises safer, more effective cancer therapy

by Jim Lynch,University of MichiganiRAI system schematic and the experimental setup. a, 3D schematic of the iRAI system for mapping the dose deposition in a patient during RT delivery. b, CAD vi
Oncology January 04,2024
Tracking radiation treatment in real time promises safer, more effective cancer therapy

Tracking radiation treatment in real time promises safer, more effective cancer therapy

by Jim Lynch,University of MichiganiRAI system schematic and the experimental setup. a, 3D schematic of the iRAI system for mapping the dose deposition in a patient during RT delivery. b, CAD vi
Oncology January 04,2024
Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer

Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer

byPerelman School of Medicine at the University of PennsylvaniaCredit: Pixabay/CC0 Public DomainOver the past decade, the approval of immune checkpoint inhibitors has revolutionized treatment fo
Oncology January 04,2024
Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer

Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer

byPerelman School of Medicine at the University of PennsylvaniaCredit: Pixabay/CC0 Public DomainOver the past decade, the approval of immune checkpoint inhibitors has revolutionized treatment fo
Oncology January 04,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com